Zai Lab Announces First Quarter 2022 Financial Results

Company to Host Conference Call and Webcast on May 11, 2022, at 8:00 a.m. ET...

Related Keywords

China , Shanghai , United States , Cambridge , Cambridgeshire , United Kingdom , Lisbon , Lisboa , Portugal , American , David Tran , Optune Lua , Josh Smiley , Eli Lilly , Seek National Reimbursement Drug List , Amgen , Global Business Services , American Society Of Clinical Oncology , Submit Zai Lab , Zai Lab , University Of Florida , Zai Lab Limited , Audit Committee , Nasdaq , Mcknight Brain Institute , Co Lilly , European Union , Public Company Accounting Oversight Board , Society Of Gynecologic Oncology , Division Of Neuro , Blueprint Medicines Corporation , European Congress , Mirati Therapeutics Inc , American Depositary Shares Adss Of The Company , Point Therapeutics Inc , Exchange Commission , American Association For Cancer Research , National Medical Products Administration , Holding Foreign Companies Accountable , Board Of Directors The Company , Lab Limited , Chief Executive Officer , Greater China , Product Highlights , Gynecologic Oncology , Tumor Treating , Treating Fields , Mirati Therapeutics , Clinical Oncology , Fast Track , Biologics License Application , Turning Point Therapeutics , Turning Point , Blinded Independent Central Review , Cullinan Oncology , Cancer Research , Blueprint Medicines , Global Rights , National Reimbursement Drug List , Asia Pacific Rights , Entasis Therapeutics , Clinical Microbiology , Infectious Diseases , Annual Conference , Holding Foreign Companies Accountable Act , American Depositary Shares , Chief Operating Officer , Nasdaq Zlab ,